SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,000 | -71.6% | 138,057 | -39.4% | 0.00% | – |
| Q2 2023 | $296,000 | +27.6% | 227,722 | +73.0% | 0.00% | – |
| Q1 2023 | $232,000 | +96.6% | 131,654 | +252.3% | 0.00% | – |
| Q4 2022 | $118,000 | -18.1% | 37,375 | +28.3% | 0.00% | – |
| Q3 2022 | $144,000 | +32.1% | 29,131 | +11.2% | 0.00% | – |
| Q2 2022 | $109,000 | -42.6% | 26,194 | -20.5% | 0.00% | – |
| Q1 2022 | $190,000 | -49.2% | 32,948 | -33.9% | 0.00% | – |
| Q4 2021 | $374,000 | -0.3% | 49,811 | +19.4% | 0.00% | – |
| Q3 2021 | $375,000 | -23.8% | 41,707 | +1.6% | 0.00% | – |
| Q2 2021 | $492,000 | +14.7% | 41,062 | +20.2% | 0.00% | – |
| Q1 2021 | $429,000 | -11.5% | 34,167 | +9.8% | 0.00% | – |
| Q4 2020 | $485,000 | +219.1% | 31,125 | +93.1% | 0.00% | – |
| Q3 2020 | $152,000 | +56.7% | 16,115 | +48.7% | 0.00% | – |
| Q2 2020 | $97,000 | +44.8% | 10,839 | +3.7% | 0.00% | – |
| Q1 2020 | $67,000 | -75.9% | 10,454 | -68.5% | 0.00% | – |
| Q4 2019 | $278,000 | +14.4% | 33,214 | +23.6% | 0.00% | – |
| Q3 2019 | $243,000 | -50.9% | 26,875 | -41.5% | 0.00% | – |
| Q2 2019 | $495,000 | -7.5% | 45,951 | -18.3% | 0.00% | – |
| Q1 2019 | $535,000 | +50.3% | 56,231 | +82.1% | 0.00% | – |
| Q4 2018 | $356,000 | -29.9% | 30,881 | +2.9% | 0.00% | – |
| Q3 2018 | $508,000 | +35.8% | 30,020 | +13.7% | 0.00% | – |
| Q2 2018 | $374,000 | -24.6% | 26,405 | +1.1% | 0.00% | – |
| Q1 2018 | $496,000 | -28.6% | 26,129 | -38.4% | 0.00% | – |
| Q4 2017 | $695,000 | +306.4% | 42,387 | +269.5% | 0.00% | – |
| Q3 2017 | $171,000 | +402.9% | 11,472 | +195.4% | 0.00% | – |
| Q2 2017 | $34,000 | +13.3% | 3,883 | -34.6% | 0.00% | – |
| Q1 2017 | $30,000 | +20.0% | 5,940 | -26.8% | 0.00% | – |
| Q4 2016 | $25,000 | -72.5% | 8,111 | -58.7% | 0.00% | – |
| Q3 2016 | $91,000 | -34.1% | 19,660 | -17.5% | 0.00% | – |
| Q2 2016 | $138,000 | -4.2% | 23,820 | 0.0% | 0.00% | – |
| Q1 2016 | $144,000 | -55.7% | 23,820 | -33.0% | 0.00% | – |
| Q4 2015 | $325,000 | +187.6% | 35,556 | +78.3% | 0.00% | – |
| Q3 2015 | $113,000 | -13.1% | 19,947 | +70.5% | 0.00% | – |
| Q2 2015 | $130,000 | -22.6% | 11,700 | +9.3% | 0.00% | – |
| Q1 2015 | $168,000 | -28.8% | 10,700 | -31.0% | 0.00% | – |
| Q4 2014 | $236,000 | +41.3% | 15,500 | 0.0% | 0.00% | – |
| Q3 2014 | $167,000 | -46.6% | 15,500 | -24.4% | 0.00% | – |
| Q2 2014 | $313,000 | -15.4% | 20,500 | -0.1% | 0.00% | – |
| Q1 2014 | $370,000 | +6.6% | 20,520 | -18.0% | 0.00% | – |
| Q4 2013 | $347,000 | +28.0% | 25,020 | -3.4% | 0.00% | – |
| Q3 2013 | $271,000 | +36.9% | 25,895 | +2.1% | 0.00% | – |
| Q2 2013 | $198,000 | – | 25,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |